<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">nss</journal-id>
      <journal-id journal-id-type="pmc">nss</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34584477</article-id>
      <article-id pub-id-type="pmc">8464343</article-id>
      <article-id pub-id-type="publisher-id">317746</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S317746</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The Association Between Asthma and Narcolepsy: A Nationwide Case-Control Study in Taiwan</article-title>
        <alt-title alt-title-type="running-authors">Chen et al</alt-title>
        <alt-title alt-title-type="running-title">Chen et al</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8462-1311</contrib-id>
          <name>
            <surname>Chen</surname>
            <given-names>Tien-Yu</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff0002">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff0003">
<sup>3</sup>
</xref>
          <xref ref-type="author-notes" rid="ft0001">*</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9304-2856</contrib-id>
          <name>
            <surname>Su</surname>
            <given-names>Vincent Yi-Fong</given-names>
          </name>
          <xref ref-type="aff" rid="aff0004">
<sup>4</sup>
</xref>
          <xref ref-type="aff" rid="aff0005">
<sup>5</sup>
</xref>
          <xref ref-type="author-notes" rid="ft0001">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Chung-Hsin</given-names>
          </name>
          <xref ref-type="aff" rid="aff0006">
<sup>6</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4576-9900</contrib-id>
          <name>
            <surname>Chung</surname>
            <given-names>Chi-Hsiang</given-names>
          </name>
          <xref ref-type="aff" rid="aff0007">
<sup>7</sup>
</xref>
          <xref ref-type="aff" rid="aff0008">
<sup>8</sup>
</xref>
          <xref ref-type="aff" rid="aff0009">
<sup>9</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsai</surname>
            <given-names>Chia-Kuang</given-names>
          </name>
          <xref ref-type="aff" rid="aff0003">
<sup>3</sup>
</xref>
          <xref ref-type="aff" rid="aff0010">
<sup>10</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5696-2557</contrib-id>
          <name>
            <surname>Peng</surname>
            <given-names>Chung-Kan</given-names>
          </name>
          <xref ref-type="aff" rid="aff0003">
<sup>3</sup>
</xref>
          <xref ref-type="aff" rid="aff0011">
<sup>11</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lai</surname>
            <given-names>Hsiao-Ching</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chien</surname>
            <given-names>Wu-Chien</given-names>
          </name>
          <xref ref-type="aff" rid="aff0007">
<sup>7</sup>
</xref>
          <xref ref-type="aff" rid="aff0008">
<sup>8</sup>
</xref>
          <xref ref-type="aff" rid="aff0009">
<sup>9</sup>
</xref>
          <xref ref-type="aff" rid="aff0012">
<sup>12</sup>
</xref>
          <xref ref-type="corresp" rid="an0001"/>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5881-7089</contrib-id>
          <name>
            <surname>Tzeng</surname>
            <given-names>Nian-Sheng</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff0013">
<sup>13</sup>
</xref>
          <xref ref-type="corresp" rid="an0002"/>
        </contrib>
        <aff id="aff0001"><label>1</label><institution>Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
        <aff id="aff0002"><label>2</label><institution>Institute of Brain Science, National Yang Ming Chiao Tung University</institution>, <addr-line>Taipei</addr-line>, <addr-line>112</addr-line>, <country>Taiwan</country></aff>
        <aff id="aff0003"><label>3</label><institution>Sleep Medicine Center, Tri-Service General Hospital, School of Medicine, National Defense Medical Center</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
        <aff id="aff0004"><label>4</label><institution>Department of Internal Medicine, Taipei City Hospital</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
        <aff id="aff0005"><label>5</label><institution>Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University</institution>, <addr-line>Taipei</addr-line>, <addr-line>112</addr-line>, <country>Taiwan</country></aff>
        <aff id="aff0006"><label>6</label><institution>Department of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital</institution>, <addr-line>Taichung</addr-line>, <country>Taiwan</country></aff>
        <aff id="aff0007"><label>7</label><institution>Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
        <aff id="aff0008"><label>8</label><institution>School of Public Health, National Defense Medical Center</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
        <aff id="aff0009"><label>9</label><institution>Taiwanese Injury Prevention and Safety Promotion Association</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
        <aff id="aff0010"><label>10</label><institution>Department of Neurology, Tri-Service General Hospital, School of Medicine, National Defense Medical Center</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
        <aff id="aff0011"><label>11</label><institution>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tri-Service General Hospital, School of Medicine, National Defense Medical Center</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
        <aff id="aff0012"><label>12</label><institution>Graduate Institute of Life Sciences, National Defense Medical Center</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
        <aff id="aff0013"><label>13</label><institution>Student Counseling Center, National Defense Medical Center</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="an0001">Correspondence: Wu-Chien Chien <institution>Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center</institution>, <addr-line>7115R, No. 325, Section 2, Cheng-Kung Road, Neihu District</addr-line>, <addr-line>Taipei</addr-line>, <addr-line>11490</addr-line>, <country>Taiwan</country><phone>Tel +886 2-87923311, Ext. 19189</phone><fax>Fax +886 2-87927235</fax> Email chienwu@mail.ndmctsgh.edu.tw</corresp>
        <corresp id="an0002">Nian-Sheng Tzeng <institution>Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center</institution>, <addr-line>325, Section 2, Cheng-Kung Road, Neihu District</addr-line>, <addr-line>Taipei City</addr-line>, <addr-line>11490</addr-line>, <country>Taiwan</country><phone>Tel +886 2-87927299</phone><fax>Fax +886 2-87927221</fax> Email pierrens@mail.ndmctsgh.edu.tw</corresp>
        <fn id="ft0001">
          <label>*</label>
          <p>These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>9</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>13</volume>
      <fpage>1631</fpage>
      <lpage>1640</lpage>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>4</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>9</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2021 Chen et al.</copyright-statement>
        <copyright-year>2021</copyright-year>
        <copyright-holder>Chen et al.</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref>
          <license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <sec id="s2001">
          <title>Purpose</title>
          <p>Asthma, which is caused by inflammation of the airways, affects the sensitivity of nerve endings. Narcolepsy is a chronic sleep disorder that may be caused by autoimmunity. Recent studies have reported a positive association between narcolepsy and asthma. We aimed to examine the association between asthma and narcolepsy and determine the effects of therapeutic corticosteroid or bronchodilator use.</p>
        </sec>
        <sec id="s2002">
          <title>Materials and Methods</title>
          <p>We conducted a nationwide population-based, nested case-control study using Taiwan’s National Health Insurance Research Database (NHIRD) between 2000 and 2013. Subjects with narcolepsy (ICD-9-CM code 347) were enrolled, with 1:3 estimated propensity score-matched controls based on sex, age, and index year. The association between narcolepsy and asthma was assessed using multiple logistic regression analyses. The covariates included sex, age, monthly insurance premiums, geographical area of residence, urbanization level of residence, level of care, and presence of diseases related to immune response and central nervous system. The effects of corticosteroid and bronchodilator use were also analyzed.</p>
        </sec>
        <sec id="s2003">
          <title>Results</title>
          <p>Overall, 2008 subjects were identified from the NHIRD (502 patients with narcolepsy and 1506 controls). The participants with narcolepsy had almost three times the level of previous asthma diagnosis than controls. Compared to those without asthma, patients with asthma had an adjusted odds ratio (OR) of 3.181 for narcolepsy comorbidity (95% confidence interval [CI]: 2.048–4.941, <italic>p</italic>&lt;0.001). The use of inhaled corticosteroids was associated with a lower risk of narcolepsy comorbidity, with an adjusted OR of 0.465 (95% CI, 0.250–0.634; <italic>p</italic>&lt;0.001), in patients with asthma when compared to those without treatment.</p>
        </sec>
        <sec id="s2004">
          <title>Conclusion</title>
          <p>This study demonstrated a significantly higher level of previous asthma diagnosis in patients with narcolepsy. The use of inhaled corticosteroids was associated with a lower risk of narcolepsy comorbidity in asthma patients, compared to those without treatment.</p>
        </sec>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords</title>
        <kwd>asthma</kwd>
        <kwd>narcolepsy</kwd>
        <kwd>corticosteroid</kwd>
        <kwd>bronchodilators</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution>Tri-Service General Hospital Research Foundation</institution>
            </institution-wrap>
          </funding-source>
        </award-group>
        <funding-statement>This work was supported by the Tri-Service General Hospital Research Foundation (TSGH-C108-003, TSGH-C108-151, TSGH-B-109-010, TSGH-D-109197, TSGH-B-110-012, TSGH-D-110176, and TSGH-E-110240), the Taoyuan Armed Forces General Hospital (TYAFGH-A-110020), and the Medical Affairs Bureau, Ministry of Defense of Taiwan (MND-MAB-110-087).</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="1"/>
        <table-count count="9"/>
        <ref-count count="46"/>
        <page-count count="10"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="S0001">
      <title>Introduction</title>
      <p>Narcolepsy is a neurological disorder that affects the brain’s ability to control sleep and wakefulness. There are two main types of narcolepsy: type 1 and type 2.<xref rid="cit0001" ref-type="bibr">1–3</xref> All types of narcolepsy may cause excessive daytime sleepiness, sleep paralysis, hypnagogic/hypnopompic hallucination, early rapid eye movement (REM) sleep, and fragmented sleep. The difference between type 1 and type 2 narcolepsy is that the former may cause sudden loss of muscle tone (cataplexy).<xref rid="cit0001" ref-type="bibr">1–3</xref> Multiple factors may be related to the pathophysiology of narcolepsy. Besides impaired function due to excessive daytime sleepiness, the high incidence of comorbidities, including mood disorders and other sleep disorders, affects daily function<xref rid="cit0004" ref-type="bibr">4–7</xref> and may contribute to incidents such as motor vehicle accidents.<xref rid="cit0006" ref-type="bibr">6</xref>,<xref rid="cit0008" ref-type="bibr">8</xref>,<xref rid="cit0009" ref-type="bibr">9</xref> A previous review reported a delayed diagnosis of narcolepsy by up to 15 years.<xref rid="cit0010" ref-type="bibr">10</xref> Although variables associated with delayed narcolepsy diagnosis have been identified, a lack of symptom recognition and the abovementioned comorbidities can result in misdiagnosis prior to the final narcolepsy diagnosis.<xref rid="cit0010" ref-type="bibr">10–13</xref></p>
      <p>Asthma is a chronic inflammatory lung disease with exacerbation, which may contribute to morbidity and mortality.<xref rid="cit0014" ref-type="bibr">14–16</xref> Several recent studies have reported a positive association between narcolepsy and asthma. Early REM sleep and fragmented sleep in narcolepsy can cause irregular respiratory responses and result in breathing disorders, such as asthma.<xref rid="cit0017" ref-type="bibr">17</xref> Asthma and narcolepsy are considered to share common immunopathological mechanisms.<xref rid="cit0018" ref-type="bibr">18</xref>,<xref rid="cit0019" ref-type="bibr">19</xref> One study reported that the prevalence of comorbid immunopathological diseases is high in patients with narcolepsy and that cataplexy is significantly more severe in patients with comorbid immunopathological disease and narcolepsy.<xref rid="cit0020" ref-type="bibr">20</xref> Another study conducted by Aydinoz et al reported contrasting results in childhood narcolepsy; they found that the frequency of allergic conditions, particularly asthma and allergic rhinitis, was markedly lower in type 1 narcolepsy than in type 2 narcolepsy.<xref rid="cit0021" ref-type="bibr">21</xref> Alomar et al, in a study from Saudi Arabia, enrolled 80 consecutive patients with narcolepsy and found that allergic disorders were associated with both type 1 and type 2 narcolepsy.<xref rid="cit0022" ref-type="bibr">22</xref> Since most of the results reported to date are controversial and no nationwide population-based study has clarified the association between asthma and narcolepsy, the present study aimed to investigate the association between asthma and narcolepsy in Taiwan using the National Health Insurance Research Database (NHIRD), a nationwide population-based claims database.</p>
    </sec>
    <sec id="S0002">
      <title>Materials and Methods</title>
      <sec id="S0002-S2001">
        <title>Data Source</title>
        <p>The National Health Insurance (NHI) Program was launched in Taiwan in 1995. As of June 2009, the program had established contracts with 97% of medical providers with approximately 23 million beneficiaries, accounting for more than 99% of the entire population. Details of the program have been provided in previous reports.<xref rid="cit0006" ref-type="bibr">6</xref>,<xref rid="cit0007" ref-type="bibr">7</xref>,<xref rid="cit0023" ref-type="bibr">23–28</xref> The NHIRD contains all the claims data of the beneficiaries, and it uses the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes to record the diagnoses. The accuracy of diagnoses recorded in the NHIRD, such as pneumonia,<xref rid="cit0025" ref-type="bibr">25</xref> asthma,<xref rid="cit0029" ref-type="bibr">29</xref> sleep apnea,<xref rid="cit0030" ref-type="bibr">30</xref> and tuberculosis,<xref rid="cit0031" ref-type="bibr">31</xref> has been validated.</p>
        <p>A subset of the NHIRD, the Longitudinal Health Insurance Database (LHID), which consists of the data of 1 million randomized population samples accrued between 2000 and 2013, was used to study the association between asthma and the risk of narcolepsy. The Institutional Review Board of the Tri-Service General Hospital approved this study and waived the requirement for written informed consent (IRB No. 2-107-05-026).</p>
      </sec>
      <sec id="S0002-S2002">
        <title>Study Design and Sampled Participants</title>
        <p>To undertake this population-based, retrospective case-control study, we included subjects aged ≥ 6 years diagnosed with narcolepsy, based on the ICD-9-CM code (347), by board-certified sleep medicine specialists, including neurologists, psychiatrists, pulmonologists, and otorhinolaryngologists, between January 1, 2000, and December 31, 2013. The exclusion criteria were as follows: (1) age of &lt;6 years on the study entry date and (2) unknown sex. The patients with narcolepsy and the control subjects were selected using a 1:3 estimated propensity score-matching based on sex, age, and index year.</p>
      </sec>
      <sec id="S0002-S2003">
        <title>Major Outcome Measure</title>
        <p>The study aimed to evaluate the association between asthma and narcolepsy. Previous asthma diagnosis was investigated in both the narcolepsy and control groups. Each enrolled subject with asthma was required to have had at least six outpatient clinic visits or one hospitalization during the study period with a diagnosis code of 493. This method used in this study to choose the subjects with asthma was validated in a previous study with 92% sensitivity.<xref rid="cit0029" ref-type="bibr">29</xref>
<xref ref-type="fig" rid="f0001">Figure 1</xref> shows a detailed flowchart of the subject selection process.<fig id="f0001" fig-type="figure" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flowchart outlining the sample selection procedure from Taiwan’s National Health Insurance Research Database.</p></caption><graphic content-type="print-only" xlink:href="NSS-13-1631-g0001"/></fig></p>
      </sec>
      <sec id="S0002-S2004">
        <title>Potential Confounders</title>
        <p>The covariates included sex, age group (6–11, 12–19, 20–44, 45–64, and ≥65 years), monthly insurance premium (in New Taiwan Dollars [NT$]; &lt;18,000, 18,000–34,999, and ≥35,000), geographical area of residence (northern, central, southern, eastern Taiwan, and the outer islands), urbanization level of residence (levels 1–4), and level of care (medical center, regional, and local hospital). The urbanization level of residence was defined based on the population and various indicators of the level of development. Level 1 was characterized by a population of &gt;1,250,000 individuals in a region with political, economic, cultural, and metropolitan development. Level 2 was characterized by a population of 500,000–1,249,999 individuals, with the area playing an important role in politics, economy, and culture. Urbanization levels 3 and 4 were characterized by populations of 149,999–499,999 and &lt;149,999 individuals, respectively.<xref rid="cit0032" ref-type="bibr">32</xref></p>
        <p>Several confounders may be associated with asthma and narcolepsy. We selected several diseases related to immune response, such as atopic dermatitis, allergic rhinitis, influenza, and autoimmune diseases, as confounding factors because of the possible immune impacts on both asthma and narcolepsy. Diseases related to the central nervous system (CNS), such as psychiatric disorders, CNS infection, cerebral palsy, obstructive sleep apnea (OSA), and insomnia, were also selected as confounders due to their possible impacts on sleep and breathing. These factors were assessed in the year preceding the study entry year. The concomitant use of medications for obstructive lung diseases, such as inhaled/oral/injected corticosteroids and bronchodilators, was also evaluated.</p>
      </sec>
      <sec id="S0002-S2005">
        <title>Statistical Analysis</title>
        <p>All statistical analyses were performed using SPSS for Windows (version 22.0; IBM Corp., Armonk, NY, USA). The distributions of age, sex, and comorbidities in the patients with narcolepsy and the controls were evaluated using the Chi-square test. Multivariate logistic regression analyses were used to calculate the odds ratios (ORs) with 95% confidence intervals (CIs; 95% CI) to assess the association between asthma and narcolepsy, after adjusting for the potential confounding effects of comorbidities. Our logistic regression analyses used narcolepsy diagnosis as the dependent variable and other clinical predictors or potential confounders as the independent variables. Subgroup analyses for evaluating the association between asthma diagnosis and the risk of narcolepsy were conducted after stratification based on sex, age, and comorbidities. Logistic regression analysis was used to assess the association between medications used for obstructive lung diseases in asthma patients and narcolepsy comorbidity. Statistical significance was set at <italic>p</italic>&lt;0.05.</p>
      </sec>
    </sec>
    <sec id="S0003">
      <title>Results</title>
      <p>In this study, 2008 subjects were enrolled (502 subjects with narcolepsy and 1506 subjects without narcolepsy). <xref rid="t0001" ref-type="table">Table 1</xref> shows the sex, age, monthly insurance premiums, comorbidities, area of residence, urbanization level, level of care, and medication use for obstructive lung diseases in narcolepsy patients and controls. Compared with the controls, a higher proportion of narcoleptic patients tended to have asthma, psychiatric disorders, CNS infection, OSA, and insomnia, but a lower proportion of the patients had influenza; they also had a higher likelihood of living in urbanization levels 1 or 2 and in the northern region and outer islands of Taiwan. In addition, narcoleptic patients tended to have a higher likelihood of inhaled/oral/injected corticosteroid use.<table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1</label><caption><p>Characteristics of Study at the Baseline</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Variables</th><th colspan="2" rowspan="1">Total</th><th colspan="2" rowspan="1">Narcolepsy</th><th colspan="2" rowspan="1">Controls</th><th rowspan="2" colspan="1"><italic>P</italic></th></tr><tr><th rowspan="1" colspan="1">n</th><th rowspan="1" colspan="1">%</th><th rowspan="1" colspan="1">n</th><th rowspan="1" colspan="1">%</th><th rowspan="1" colspan="1">n</th><th rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Total</td><td rowspan="1" colspan="1">2008</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">502</td><td rowspan="1" colspan="1">25.00</td><td rowspan="1" colspan="1">1506</td><td rowspan="1" colspan="1">75.00</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Previous Asthma Diagnosis</td><td rowspan="1" colspan="1">100</td><td rowspan="1" colspan="1">4.98</td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">9.76</td><td rowspan="1" colspan="1">51</td><td rowspan="1" colspan="1">3.39</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Sex</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.999</td></tr><tr><td rowspan="1" colspan="1"> Male</td><td rowspan="1" colspan="1">1200</td><td rowspan="1" colspan="1">59.76</td><td rowspan="1" colspan="1">300</td><td rowspan="1" colspan="1">59.76</td><td rowspan="1" colspan="1">900</td><td rowspan="1" colspan="1">59.76</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Female</td><td rowspan="1" colspan="1">808</td><td rowspan="1" colspan="1">40.24</td><td rowspan="1" colspan="1">202</td><td rowspan="1" colspan="1">40.24</td><td rowspan="1" colspan="1">606</td><td rowspan="1" colspan="1">40.24</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Age (years)</td><td colspan="2" rowspan="1">43.53±24.29</td><td colspan="2" rowspan="1">42.46±24.57</td><td colspan="2" rowspan="1">43.88±24.20</td><td rowspan="1" colspan="1">0.255</td></tr><tr><td rowspan="1" colspan="1">Age group (years)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.999</td></tr><tr><td rowspan="1" colspan="1"> 6–11</td><td rowspan="1" colspan="1">112</td><td rowspan="1" colspan="1">5.58</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">5.58</td><td rowspan="1" colspan="1">84</td><td rowspan="1" colspan="1">5.58</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> 12–19</td><td rowspan="1" colspan="1">420</td><td rowspan="1" colspan="1">20.92</td><td rowspan="1" colspan="1">105</td><td rowspan="1" colspan="1">20.92</td><td rowspan="1" colspan="1">315</td><td rowspan="1" colspan="1">20.92</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> 20–44</td><td rowspan="1" colspan="1">608</td><td rowspan="1" colspan="1">5.58</td><td rowspan="1" colspan="1">152</td><td rowspan="1" colspan="1">5.58</td><td rowspan="1" colspan="1">456</td><td rowspan="1" colspan="1">5.58</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> 45–64</td><td rowspan="1" colspan="1">352</td><td rowspan="1" colspan="1">5.58</td><td rowspan="1" colspan="1">88</td><td rowspan="1" colspan="1">5.58</td><td rowspan="1" colspan="1">264</td><td rowspan="1" colspan="1">5.58</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> ≥65</td><td rowspan="1" colspan="1">516</td><td rowspan="1" colspan="1">25.70</td><td rowspan="1" colspan="1">129</td><td rowspan="1" colspan="1">25.70</td><td rowspan="1" colspan="1">387</td><td rowspan="1" colspan="1">25.70</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Insurance premium (NT$)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.993</td></tr><tr><td rowspan="1" colspan="1"> &lt;18,000</td><td rowspan="1" colspan="1">1598</td><td rowspan="1" colspan="1">79.58</td><td rowspan="1" colspan="1">400</td><td rowspan="1" colspan="1">79.68</td><td rowspan="1" colspan="1">1198</td><td rowspan="1" colspan="1">79.55</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> 18,000–34,999</td><td rowspan="1" colspan="1">247</td><td rowspan="1" colspan="1">12.30</td><td rowspan="1" colspan="1">61</td><td rowspan="1" colspan="1">12.15</td><td rowspan="1" colspan="1">186</td><td rowspan="1" colspan="1">12.35</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> ≥35,000</td><td rowspan="1" colspan="1">163</td><td rowspan="1" colspan="1">8.12</td><td rowspan="1" colspan="1">41</td><td rowspan="1" colspan="1">8.17</td><td rowspan="1" colspan="1">122</td><td rowspan="1" colspan="1">8.10</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Atopic dermatitis</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0.10</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.00</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">0.13</td><td rowspan="1" colspan="1">0.414</td></tr><tr><td rowspan="1" colspan="1">Allergic rhinitis</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">0.30</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">0.00</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">0.40</td><td rowspan="1" colspan="1">0.347</td></tr><tr><td rowspan="1" colspan="1">Psychiatric disorders</td><td rowspan="1" colspan="1">186</td><td rowspan="1" colspan="1">9.26</td><td rowspan="1" colspan="1">87</td><td rowspan="1" colspan="1">17.33</td><td rowspan="1" colspan="1">99</td><td rowspan="1" colspan="1">6.57</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">CNS infection</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">0.55</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">1.20</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0.33</td><td rowspan="1" colspan="1">0.034</td></tr><tr><td rowspan="1" colspan="1">Cerebral palsy</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">0.7</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">1.39</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">0.53</td><td rowspan="1" colspan="1">0.069</td></tr><tr><td rowspan="1" colspan="1">OSA</td><td rowspan="1" colspan="1">25</td><td rowspan="1" colspan="1">1.25</td><td rowspan="1" colspan="1">21</td><td rowspan="1" colspan="1">4.18</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">0.27</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Insomnia</td><td rowspan="1" colspan="1">37</td><td rowspan="1" colspan="1">1.84</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">5.58</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">0.60</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Influenza</td><td rowspan="1" colspan="1">23</td><td rowspan="1" colspan="1">1.15</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">0.20</td><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">1.46</td><td rowspan="1" colspan="1">0.026</td></tr><tr><td rowspan="1" colspan="1">Autoimmune diseases</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">0.70</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">0.80</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">0.66</td><td rowspan="1" colspan="1">0.759</td></tr><tr><td rowspan="1" colspan="1">Location</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"> Northern Taiwan</td><td rowspan="1" colspan="1">863</td><td rowspan="1" colspan="1">42.98</td><td rowspan="1" colspan="1">296</td><td rowspan="1" colspan="1">58.96</td><td rowspan="1" colspan="1">567</td><td rowspan="1" colspan="1">37.65</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Middle Taiwan</td><td rowspan="1" colspan="1">559</td><td rowspan="1" colspan="1">27.84</td><td rowspan="1" colspan="1">88</td><td rowspan="1" colspan="1">17.53</td><td rowspan="1" colspan="1">471</td><td rowspan="1" colspan="1">31.27</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Southern Taiwan</td><td rowspan="1" colspan="1">458</td><td rowspan="1" colspan="1">22.81</td><td rowspan="1" colspan="1">79</td><td rowspan="1" colspan="1">15.74</td><td rowspan="1" colspan="1">379</td><td rowspan="1" colspan="1">25.17</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Eastern Taiwan</td><td rowspan="1" colspan="1">108</td><td rowspan="1" colspan="1">5.38</td><td rowspan="1" colspan="1">28</td><td rowspan="1" colspan="1">5.58</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">5.31</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Out islands</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">219</td><td rowspan="1" colspan="1">9</td><td rowspan="1" colspan="1">0.60</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Urbanization level</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"> 1 (The highest)</td><td rowspan="1" colspan="1">640</td><td rowspan="1" colspan="1">31.87</td><td rowspan="1" colspan="1">188</td><td rowspan="1" colspan="1">37.45</td><td rowspan="1" colspan="1">452</td><td rowspan="1" colspan="1">30.01</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> 2</td><td rowspan="1" colspan="1">925</td><td rowspan="1" colspan="1">46.07</td><td rowspan="1" colspan="1">254</td><td rowspan="1" colspan="1">50.60</td><td rowspan="1" colspan="1">671</td><td rowspan="1" colspan="1">44.56</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> 3</td><td rowspan="1" colspan="1">159</td><td rowspan="1" colspan="1">7.92</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">3.98</td><td rowspan="1" colspan="1">139</td><td rowspan="1" colspan="1">9.23</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> 4 (The lowest)</td><td rowspan="1" colspan="1">284</td><td rowspan="1" colspan="1">14.14</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">7.97</td><td rowspan="1" colspan="1">244</td><td rowspan="1" colspan="1">16.20</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Level of care</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"> Hospital center</td><td rowspan="1" colspan="1">755</td><td rowspan="1" colspan="1">37.60</td><td rowspan="1" colspan="1">249</td><td rowspan="1" colspan="1">49.60</td><td rowspan="1" colspan="1">506</td><td rowspan="1" colspan="1">33.60</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Regional hospital</td><td rowspan="1" colspan="1">898</td><td rowspan="1" colspan="1">44.72</td><td rowspan="1" colspan="1">197</td><td rowspan="1" colspan="1">39.24</td><td rowspan="1" colspan="1">701</td><td rowspan="1" colspan="1">46.55</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Local hospital</td><td rowspan="1" colspan="1">355</td><td rowspan="1" colspan="1">17.68</td><td rowspan="1" colspan="1">56</td><td rowspan="1" colspan="1">11.16</td><td rowspan="1" colspan="1">299</td><td rowspan="1" colspan="1">19.85</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Medication for obstructive lung diseases</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"> No use</td><td rowspan="1" colspan="1">1066</td><td rowspan="1" colspan="1">53.0</td><td rowspan="1" colspan="1">240</td><td rowspan="1" colspan="1">47.81</td><td rowspan="1" colspan="1">826</td><td rowspan="1" colspan="1">54.85</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Inhaled CS only</td><td rowspan="1" colspan="1">250</td><td rowspan="1" colspan="1">12.45</td><td rowspan="1" colspan="1">71</td><td rowspan="1" colspan="1">14.14</td><td rowspan="1" colspan="1">179</td><td rowspan="1" colspan="1">11.89</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Bronchodilator only</td><td rowspan="1" colspan="1">201</td><td rowspan="1" colspan="1">10.01</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">9.96</td><td rowspan="1" colspan="1">151</td><td rowspan="1" colspan="1">10.03</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Inhaled CS &amp; bronchodilator</td><td rowspan="1" colspan="1">170</td><td rowspan="1" colspan="1">8.47</td><td rowspan="1" colspan="1">42</td><td rowspan="1" colspan="1">8.37</td><td rowspan="1" colspan="1">128</td><td rowspan="1" colspan="1">8.50</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Oral or injected CS</td><td rowspan="1" colspan="1">321</td><td rowspan="1" colspan="1">15.99</td><td rowspan="1" colspan="1">99</td><td rowspan="1" colspan="1">19.72</td><td rowspan="1" colspan="1">222</td><td rowspan="1" colspan="1">14.4</td><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><bold>Note:</bold><italic>P</italic>: Chi-square/Fisher exact test on category variables and <italic>t</italic>-test on continuous variables.</p></fn><fn id="tfn0002"><p><bold>Abbreviations:</bold> CNS, central nervous system; OSA, obstructive sleep apnea; CS, corticosteroid.</p></fn></table-wrap-foot></table-wrap>
</p>
      <p><xref rid="t0002" ref-type="table">Table 2</xref> shows the outcomes of multivariate logistic regression analysis of the factors associated with the risk of narcolepsy comorbidity. Compared with patients without asthma, those with asthma had a crude OR of 3.086 (95% CI, 2.056–4.631; <italic>p</italic>&lt;0.001) for narcolepsy comorbidity. After adjusting for sex, age, monthly income, atopic dermatitis, allergic rhinitis, allergic conjunctivitis, psychiatric disorders, CNS infection, cerebral palsy, OSA, insomnia, influenza, autoimmune diseases, geographical area of residence, urbanization level of the residence, and level of care, the adjusted OR was 3.181 (95% CI, 2.048–4.941; <italic>p</italic>&lt;0.001).<table-wrap id="t0002" orientation="portrait" position="float"><label>Table 2</label><caption><p>Multiple Logistic Regression Analysis of Factors Contributing to Narcolepsy Comorbidity</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Variables</th><th rowspan="1" colspan="1">Crude OR</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1"><italic>P</italic></th><th rowspan="1" colspan="1">Adjusted OR</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Asthma</td><td rowspan="1" colspan="1">3.086</td><td rowspan="1" colspan="1">2.056</td><td rowspan="1" colspan="1">4.631</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">3.181</td><td rowspan="1" colspan="1">2.048</td><td rowspan="1" colspan="1">4.941</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Sex</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Male</td><td rowspan="1" colspan="1">1.000</td><td rowspan="1" colspan="1">0.814</td><td rowspan="1" colspan="1">1.229</td><td rowspan="1" colspan="1">0.905</td><td rowspan="1" colspan="1">0.998</td><td rowspan="1" colspan="1">0.800</td><td rowspan="1" colspan="1">1.244</td><td rowspan="1" colspan="1">0.983</td></tr><tr><td rowspan="1" colspan="1"> Female</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Age group (years)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> 6–11</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> 12–19</td><td rowspan="1" colspan="1">1.216</td><td rowspan="1" colspan="1">0.415</td><td rowspan="1" colspan="1">3.057</td><td rowspan="1" colspan="1">0.815</td><td rowspan="1" colspan="1">0.925</td><td rowspan="1" colspan="1">0.547</td><td rowspan="1" colspan="1">1.565</td><td rowspan="1" colspan="1">0.772</td></tr><tr><td rowspan="1" colspan="1"> 20–44</td><td rowspan="1" colspan="1">0.578</td><td rowspan="1" colspan="1">0.208</td><td rowspan="1" colspan="1">1.612</td><td rowspan="1" colspan="1">0.295</td><td rowspan="1" colspan="1">0.848</td><td rowspan="1" colspan="1">0.510</td><td rowspan="1" colspan="1">1.412</td><td rowspan="1" colspan="1">0.527</td></tr><tr><td rowspan="1" colspan="1"> 45–64</td><td rowspan="1" colspan="1">1.019</td><td rowspan="1" colspan="1">0.365</td><td rowspan="1" colspan="1">2.847</td><td rowspan="1" colspan="1">0.971</td><td rowspan="1" colspan="1">0.911</td><td rowspan="1" colspan="1">0.534</td><td rowspan="1" colspan="1">1.552</td><td rowspan="1" colspan="1">0.730</td></tr><tr><td rowspan="1" colspan="1"> ≥65</td><td rowspan="1" colspan="1">1.896</td><td rowspan="1" colspan="1">0.773</td><td rowspan="1" colspan="1">4.906</td><td rowspan="1" colspan="1">0.187</td><td rowspan="1" colspan="1">0.968</td><td rowspan="1" colspan="1">0.579</td><td rowspan="1" colspan="1">1.619</td><td rowspan="1" colspan="1">0.901</td></tr><tr><td rowspan="1" colspan="1">Insurance premium (NT$)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> &lt;18,000</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> 18,000–34,999</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">0.991</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">0.997</td></tr><tr><td rowspan="1" colspan="1"> ≥35,000</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">0.991</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">0.997</td></tr><tr><td rowspan="1" colspan="1">Atopic dermatitis</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">0.997</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">0.999</td></tr><tr><td rowspan="1" colspan="1">Allergic rhinitis</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">0.997</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">0.999</td></tr><tr><td rowspan="1" colspan="1">Psychiatric disorders</td><td rowspan="1" colspan="1">2.979</td><td rowspan="1" colspan="1">2.189</td><td rowspan="1" colspan="1">4.055</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">3.272</td><td rowspan="1" colspan="1">2.338</td><td rowspan="1" colspan="1">4.581</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">CNS infection</td><td rowspan="1" colspan="1">3.361</td><td rowspan="1" colspan="1">1.103</td><td rowspan="1" colspan="1">11.951</td><td rowspan="1" colspan="1">0.034</td><td rowspan="1" colspan="1">2.296</td><td rowspan="1" colspan="1">0.603</td><td rowspan="1" colspan="1">8.742</td><td rowspan="1" colspan="1">0.223</td></tr><tr><td rowspan="1" colspan="1">Cerebral palsy</td><td rowspan="1" colspan="1">2.648</td><td rowspan="1" colspan="1">0.955</td><td rowspan="1" colspan="1">7.339</td><td rowspan="1" colspan="1">0.061</td><td rowspan="1" colspan="1">3.001</td><td rowspan="1" colspan="1">0.988</td><td rowspan="1" colspan="1">9.120</td><td rowspan="1" colspan="1">0.053</td></tr><tr><td rowspan="1" colspan="1">OSA</td><td rowspan="1" colspan="1">16.394</td><td rowspan="1" colspan="1">5.600</td><td rowspan="1" colspan="1">47.994</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">14.245</td><td rowspan="1" colspan="1">4.110</td><td rowspan="1" colspan="1">49.368</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Insomnia</td><td rowspan="1" colspan="1">9.826</td><td rowspan="1" colspan="1">4.604</td><td rowspan="1" colspan="1">20.970</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">9.635</td><td rowspan="1" colspan="1">4.272</td><td rowspan="1" colspan="1">21.728</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Influenza</td><td rowspan="1" colspan="1">0.135</td><td rowspan="1" colspan="1">0.018</td><td rowspan="1" colspan="1">1.001</td><td rowspan="1" colspan="1">0.051</td><td rowspan="1" colspan="1">0.228</td><td rowspan="1" colspan="1">0.030</td><td rowspan="1" colspan="1">1.746</td><td rowspan="1" colspan="1">0.155</td></tr><tr><td rowspan="1" colspan="1">Autoimmune diseases</td><td rowspan="1" colspan="1">1.202</td><td rowspan="1" colspan="1">0.375</td><td rowspan="1" colspan="1">3.848</td><td rowspan="1" colspan="1">0.757</td><td rowspan="1" colspan="1">1.097</td><td rowspan="1" colspan="1">0.326</td><td rowspan="1" colspan="1">3.698</td><td rowspan="1" colspan="1">0.881</td></tr><tr><td rowspan="1" colspan="1">Urbanization level</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> 1 (The highest)</td><td rowspan="1" colspan="1">2.537</td><td rowspan="1" colspan="1">1.744</td><td rowspan="1" colspan="1">3.692</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.125</td><td rowspan="1" colspan="1">1.374</td><td rowspan="1" colspan="1">3.285</td><td rowspan="1" colspan="1">0.001</td></tr><tr><td rowspan="1" colspan="1"> 2</td><td rowspan="1" colspan="1">2.309</td><td rowspan="1" colspan="1">1.604</td><td rowspan="1" colspan="1">3.324</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">2.214</td><td rowspan="1" colspan="1">1.474</td><td rowspan="1" colspan="1">3.320</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"> 3</td><td rowspan="1" colspan="1">0.878</td><td rowspan="1" colspan="1">0.494</td><td rowspan="1" colspan="1">1.561</td><td rowspan="1" colspan="1">0.657</td><td rowspan="1" colspan="1">0.904</td><td rowspan="1" colspan="1">0.495</td><td rowspan="1" colspan="1">1.651</td><td rowspan="1" colspan="1">0.743</td></tr><tr><td rowspan="1" colspan="1"> 4 (The lowest)</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Level of care</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Hospital center</td><td rowspan="1" colspan="1">2.627</td><td rowspan="1" colspan="1">1.902</td><td rowspan="1" colspan="1">2.630</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">1.749</td><td rowspan="1" colspan="1">1.206</td><td rowspan="1" colspan="1">2.537</td><td rowspan="1" colspan="1">0.003</td></tr><tr><td rowspan="1" colspan="1"> Regional hospital</td><td rowspan="1" colspan="1">1.500</td><td rowspan="1" colspan="1">1.083</td><td rowspan="1" colspan="1">2.079</td><td rowspan="1" colspan="1">0.015</td><td rowspan="1" colspan="1">1.252</td><td rowspan="1" colspan="1">0.884</td><td rowspan="1" colspan="1">1.773</td><td rowspan="1" colspan="1">0.207</td></tr><tr><td rowspan="1" colspan="1"> Local hospital</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Medication for obstructive lung diseases</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> No use</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Inhaled CS only</td><td rowspan="1" colspan="1">0.498</td><td rowspan="1" colspan="1">0.241</td><td rowspan="1" colspan="1">0.865</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">0.337</td><td rowspan="1" colspan="1">0.198</td><td rowspan="1" colspan="1">0.785</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1"> Bronchodilator only</td><td rowspan="1" colspan="1">0.972</td><td rowspan="1" colspan="1">0.753</td><td rowspan="1" colspan="1">1.184</td><td rowspan="1" colspan="1">0.186</td><td rowspan="1" colspan="1">0.803</td><td rowspan="1" colspan="1">0.660</td><td rowspan="1" colspan="1">1.026</td><td rowspan="1" colspan="1">0.083</td></tr><tr><td rowspan="1" colspan="1"> Inhaled CS &amp; bronchodilator</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1"> Oral or injected CS</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td></tr></tbody></table><table-wrap-foot><fn id="tfn0003"><p><bold>Note:</bold> Location not included given collinearity with urbanization level.</p></fn><fn id="tfn0004"><p><bold>Abbreviations:</bold> OR, odds ratio; CI, confidence interval; Adjusted OR, Adjusted OR: Adjusted variables as sex, age, insured premium, atopic dermatitis, allergic rhinitis, psychiatric disorders, CNS infection, cerebral palsy, OSA, insomnia, influenza, autoimmune diseases, urbanization level, level of care.</p></fn></table-wrap-foot></table-wrap>
</p>
      <p><xref rid="t0003" ref-type="table">Table 3</xref> shows the effects of medication use on the association between asthma and narcolepsy comorbidity. Compared with the patients in the asthma group who did not use medication, those who used only inhaled corticosteroids had an adjusted OR of 0.465 (95% CI, 0.250–0.634; <italic>p</italic>&lt;0.001) for narcolepsy comorbidity; no significant difference was observed for the bronchodilator-only group among the patients with asthma.<table-wrap id="t0003" orientation="portrait" position="float"><label>Table 3</label><caption><p>Association Between Medication for Obstructive Lung Diseases in Asthma Patients and Narcolepsy Comorbidity</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Medication for Obstructive Lung Diseases</th><th rowspan="1" colspan="1">Crude OR</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1"><italic>P</italic></th><th rowspan="1" colspan="1">Adjusted OR</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">No use</td><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Reference</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Inhaled corticosteroid only</td><td rowspan="1" colspan="1">0.442</td><td rowspan="1" colspan="1">0.231</td><td rowspan="1" colspan="1">0.598</td><td rowspan="1" colspan="1">&lt;0.001</td><td rowspan="1" colspan="1">0.465</td><td rowspan="1" colspan="1">0.250</td><td rowspan="1" colspan="1">0.634</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">Bronchodilator only</td><td rowspan="1" colspan="1">0.857</td><td rowspan="1" colspan="1">0.669</td><td rowspan="1" colspan="1">0.997</td><td rowspan="1" colspan="1">0.048</td><td rowspan="1" colspan="1">0.870</td><td rowspan="1" colspan="1">0.683</td><td rowspan="1" colspan="1">1.076</td><td rowspan="1" colspan="1">0.075</td></tr><tr><td rowspan="1" colspan="1">Inhaled corticosteroid and bronchodilator</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1">Oral or injected corticosteroid</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td></tr></tbody></table><table-wrap-foot><fn id="tfn0005"><p><bold>Note:</bold> Location not included given collinearity with urbanization level.</p></fn><fn id="tfn0006"><p><bold>Abbreviations:</bold> OR, odds ratio; CI, confidence interval; Adjusted OR, Adjusted variables as sex, age, asthma, insured premium, atopic dermatitis, allergic rhinitis, psychiatric disorders, CNS infection, cerebral palsy, OSA, insomnia, influenza, autoimmune diseases, urbanization level, level of care, medication for obstructive lung diseases; CNS, central nervous system; OSA, obstructive sleep apnea; CS, corticosteroid.</p></fn></table-wrap-foot></table-wrap>
</p>
    </sec>
    <sec id="S0004">
      <title>Discussion</title>
      <sec id="S0004-S2001">
        <title>Asthma, Narcolepsy, and Corticosteroid Use</title>
        <p>This study reports several noteworthy findings. First, previous asthma diagnosis in patients with narcolepsy was almost three times higher than that in the controls. In contrast to previous studies on the relationship between asthma and narcolepsy,<xref rid="cit0017" ref-type="bibr">17</xref>,<xref rid="cit0020" ref-type="bibr">20–22</xref> we used a nationwide claims database and a larger sample. Second, compared to those without asthma, patients with asthma had an adjusted OR of approximately 3.181 for narcolepsy comorbidity. Third, we investigated the effects of corticosteroid and bronchodilator use and found that the use of inhaled corticosteroids, as opposed to bronchodilators, was associated with a lower risk of narcolepsy comorbidity in patients with asthma. To the best of our knowledge, this is the first study to examine the association between asthma and narcolepsy and the effects of medication use for obstructive lung diseases in asthma using a nationwide population-based database.</p>
        <p>Compared with previous studies on the association between asthma and narcolepsy, this study has several key points. First, it was a retrospective case-control study that used a large nationwide database, when compared with other retrospective chart reviews that used small sample sizes.<xref rid="cit0020" ref-type="bibr">20</xref>,<xref rid="cit0021" ref-type="bibr">21</xref> Second, we exclusively examined the association between asthma and narcolepsy instead of analyzing the relationship between several sleep disorders and allergic diseases.<xref rid="cit0017" ref-type="bibr">17</xref>,<xref rid="cit0020" ref-type="bibr">20</xref>,<xref rid="cit0021" ref-type="bibr">21</xref> Third, we examined the effects of inhaled corticosteroids on the risk of narcolepsy comorbidity in patients with asthma; the results showed an almost 50% decrease of narcolepsy comorbidity compared with those without medication use.</p>
        <p>Previous studies have reported that corticosteroid treatment for patients with asthma may decrease the risk of asthma-related death,<xref rid="cit0033" ref-type="bibr">33</xref> lung cancer,<xref rid="cit0034" ref-type="bibr">34</xref> and chronic kidney disease (CKD).<xref rid="cit0023" ref-type="bibr">23</xref> However, some studies have found that the effects of corticosteroids vary with other diseases such as cancer, schizophrenia, and dry eye syndrome.<xref rid="cit0035" ref-type="bibr">35–37</xref> A larger clinical trial for asthma patients using corticosteroids or other medications is therefore needed to confirm this association.</p>
      </sec>
      <sec id="S0004-S2002">
        <title>Potential Mechanisms of the Association Between Asthma and Narcolepsy</title>
        <p>The “orchestration” of pro-inflammatory cytokines plays an important role in the pathogenesis of allergy-related diseases such as asthma.<xref rid="cit0038" ref-type="bibr">38</xref> T-helper lymphocytes, key factors in the pathogenesis of asthma, can induce B cells to synthesize and secrete immunoglobulin E through the production of interleukin-4. Histamine, prostaglandins, leukotrienes, and kinins also contribute to the pathogenesis of asthma.<xref rid="cit0039" ref-type="bibr">39</xref> Several previous reports demonstrated the global activation of T-cells, including CD4+ T cells and regulatory T cells, in type 1 narcolepsy patients.<xref rid="cit0040" ref-type="bibr">40</xref> Recent data regarding Pandemrix-vaccination-associated type 1 narcolepsy have shown that the vaccinated patients had enhanced T-cell immunity to orexins possibly triggered by viral antigens.<xref rid="cit0041" ref-type="bibr">41</xref>,<xref rid="cit0042" ref-type="bibr">42</xref> These findings provide evidence for the T-cell-mediated autoimmune origin of type 1 narcolepsy. In type 2 narcolepsy, the role of the immune system is unclear. However, some studies have reported that autoimmune diseases are associated with type 2 narcolepsy.<xref rid="cit0022" ref-type="bibr">22</xref>,<xref rid="cit0043" ref-type="bibr">43</xref> Further research is warranted to investigate the association between narcolepsy and autoimmune response.</p>
        <p>Another study has shown that narcolepsy with hypocretin deficiency is associated with human leukocyte antigen (HLA) and T-cell receptor (TCR) polymorphisms, suggesting that an autoimmune process targets a peptide unique to hypocretin-producing neurons via specific HLA-peptide-TCR interactions.<xref rid="cit0044" ref-type="bibr">44</xref> In the present study, corticosteroid use was associated with a lower risk of narcolepsy comorbidity in patients with asthma. Since corticosteroids can suppress the autoimmune process, we hypothesize that corticosteroids may decrease the risk of narcolepsy comorbidity by the mechanism of inhibition of autoimmune processes as a collateral effect.</p>
        <p>In the present study, higher urbanization level of residence and level of care were associated with the risk of narcolepsy comorbidity. One possible reason is that air pollutants, such as ozone, sulfur dioxide, nitrogen dioxide, and particulates, which are prevalent in the higher urbanization areas, can contribute to the onset or exacerbation of symptoms and decreased pulmonary function in patients by inducing T cell-mediated inflammation;<xref rid="cit0045" ref-type="bibr">45</xref>,<xref rid="cit0046" ref-type="bibr">46</xref> This T-cell induction, consequently, may be involved in the pathogenesis of narcolepsy. This finding also suggests that socioeconomic status may play a role in the association between asthma and narcolepsy.</p>
      </sec>
      <sec id="S0004-S2003">
        <title>Strengths of This Study</title>
        <p>This study has several strengths. First, since narcolepsy is a rare disorder, a nationwide population-based study is important for obtaining information. Second, although the diagnosis of narcolepsy in the NHIRD has not been previously validated, the diagnoses of several respiratory diseases, such as asthma,<xref rid="cit0029" ref-type="bibr">29</xref> sleep apnea,<xref rid="cit0030" ref-type="bibr">30</xref> pneumonia,<xref rid="cit0030" ref-type="bibr">30</xref> and tuberculosis,<xref rid="cit0031" ref-type="bibr">31</xref> have been validated. Third, since the NHIRD contains the records of medications for asthma, we analyzed the effects of corticosteroids and bronchodilators and inferred that the appropriate use of inhaled corticosteroids for asthma patients may lower the subsequent risk of narcolepsy comorbidity.</p>
      </sec>
      <sec id="S0004-S2004">
        <title>Limitations of This Study</title>
        <p>This study had some limitations. First, the diagnoses of asthma and narcolepsy were determined based on the ICD-9-CM codes instead of validated structural diagnostic instruments. Moreover, we could not identify the types of narcolepsy in our study. However, the diagnosis of asthma was previously validated,<xref rid="cit0029" ref-type="bibr">29</xref> and we used strict criteria to identify cases of narcolepsy in our database. The distinction between type 1 (with cataplexy) and type 2 narcolepsy (without cataplexy) could not be identified using the ICD-9-CM codes. In addition, idiopathic hypersomnia, severe sleep apnea, sleep deprivation, and circadian rhythm disorders may be recorded as narcolepsy, whereas disturbed night sleep in patients with narcolepsy may have been recorded as insomnia. Nonetheless, the National Health Insurance Administration in Taiwan has strived to determine the accuracy of diagnoses in the database. Furthermore, we enrolled only narcoleptic patients diagnosed by board-certified sleep medicine specialists. Second, the authors could not measure some factors that may have influenced the results. For instance, coffee consumption and cigarette smoking, which were not assessed in the database, are associated with daytime sleepiness and airway stimulation. Third, the average age at narcolepsy diagnosis was higher in this study than in studies from other countries, and the delayed diagnosis of narcolepsy in Taiwan should be considered. Poor patient insights and low clinician awareness of this disorder may explain this finding. Further verification is required to generalize our findings.</p>
      </sec>
    </sec>
    <sec id="S0005">
      <title>Conclusion</title>
      <p>This study demonstrated a significantly higher proportion of previous asthma diagnosis in patients with narcolepsy. Compared with not using medication, the use of inhaled corticosteroids was associated with a lower risk of narcolepsy comorbidity in patients with asthma, and no significant difference was observed for the use of bronchodilators. Clinicians should be aware of the possibility of narcolepsy following the diagnosis of asthma. Further studies are needed to explore the underlying mechanisms of these two diseases.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>This study is based in part on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance of the Department of Health, Taiwan, and managed by National Health Research Institutes, Taiwan. The interpretation and conclusions contained in this article do not represent those of the Bureau of National Health Insurance, the Department of Health, or the National Health Research Institutes. All data accessed complied with relevant data protection and privacy regulations. Tien-Yu Chen and Vincent Yi-Fong Su contributed equally as first authors. Wu-Chien Chien and Nian-Sheng Tzeng contributed equally as corresponding authors.</p>
    </ack>
    <sec id="S0006">
      <title>Abbreviations</title>
      <p>CI, confidence interval; CKD, chronic kidney disease; CNS, central nervous system; CS, corticosteroid; HLA, human leukocyte antigen; ICD, International Classification of Diseases; LHID, Longitudinal Health Insurance Database; NHIRD, National Health Insurance Research Database; OR, Odds ratio; OSA, obstructive sleep apnea; TCR, T-cell receptor.</p>
    </sec>
    <sec id="S0007" sec-type="COI-statement">
      <title>Disclosure</title>
      <p>The authors declare no conflicts of interest for this work.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Murray</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Foley</surname><given-names>A</given-names></string-name>. <article-title>Narcolepsy</article-title>. <source><italic toggle="yes">Can Med Assoc J</italic></source>. <year>1974</year>;<volume>110</volume>(<issue>1</issue>):<fpage>63</fpage>–<lpage>66</lpage>.<pub-id pub-id-type="pmid">4809449</pub-id></mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zeman</surname><given-names>A</given-names></string-name>, <string-name><surname>Britton</surname><given-names>T</given-names></string-name>, <string-name><surname>Douglas</surname><given-names>N</given-names></string-name>, et al. <article-title>Narcolepsy and excessive daytime sleepiness</article-title>. <source><italic toggle="yes">BMJ</italic></source>. <year>2004</year>;<volume>329</volume>(<issue>7468</issue>):<fpage>724</fpage>–<lpage>728</lpage>.<pub-id pub-id-type="pmid">15388615</pub-id></mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Dauvilliers</surname><given-names>Y</given-names></string-name>, <string-name><surname>Arnulf</surname><given-names>I</given-names></string-name>, <string-name><surname>Mignot</surname><given-names>E</given-names></string-name>. <article-title>Narcolepsy with cataplexy</article-title>. <source><italic toggle="yes">Lancet</italic></source>. <year>2007</year>;<volume>369</volume>(<issue>9560</issue>):<fpage>499</fpage>–<lpage>511</lpage>.<pub-id pub-id-type="pmid">17292770</pub-id></mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rocca</surname><given-names>FL</given-names></string-name>, <string-name><surname>Pizza</surname><given-names>F</given-names></string-name>, <string-name><surname>Ricci</surname><given-names>E</given-names></string-name>, <string-name><surname>Plazzi</surname><given-names>G</given-names></string-name>. <article-title>Narcolepsy during childhood: an update</article-title>. <source><italic toggle="yes">Neuropediatrics</italic></source>. <year>2015</year>;<volume>46</volume>(<issue>3</issue>):<fpage>181</fpage>–<lpage>198</lpage>.<pub-id pub-id-type="pmid">25961600</pub-id></mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Postiglione</surname><given-names>E</given-names></string-name>, <string-name><surname>Antelmi</surname><given-names>E</given-names></string-name>, <string-name><surname>Pizza</surname><given-names>F</given-names></string-name>, <string-name><surname>Lecendreux</surname><given-names>M</given-names></string-name>, <string-name><surname>Dauvilliers</surname><given-names>Y</given-names></string-name>, <string-name><surname>Plazzi</surname><given-names>G</given-names></string-name>. <article-title>The clinical spectrum of childhood narcolepsy</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2018</year>;<volume>38</volume>:<fpage>70</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">28666745</pub-id></mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tzeng</surname><given-names>NS</given-names></string-name>, <string-name><surname>Hsing</surname><given-names>SC</given-names></string-name>, <string-name><surname>Chung</surname><given-names>CH</given-names></string-name>, et al. <article-title>The risk of hospitalization for motor vehicle accident injury in narcolepsy and the benefits of stimulant use: a nationwide cohort study in Taiwan</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2019</year>;<volume>15</volume>(<issue>6</issue>):<fpage>881</fpage>–<lpage>889</lpage>.<pub-id pub-id-type="pmid">31138389</pub-id></mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hung</surname><given-names>YY</given-names></string-name>, <string-name><surname>Yang</surname><given-names>LH</given-names></string-name>, <string-name><surname>Stubbs</surname><given-names>B</given-names></string-name>, et al. <article-title>Efficacy and tolerability of deep transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Prog Neuropsychopharmacol Biol Psychiatry</italic></source>. <year>2020</year>;<volume>99</volume>:<fpage>109850</fpage>.<pub-id pub-id-type="pmid">31863873</pub-id></mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bartels</surname><given-names>EC</given-names></string-name>, <string-name><surname>Kusakcioglu</surname><given-names>O</given-names></string-name>. <article-title>Narcolepsy: a possible cause of automobile accidents</article-title>. <source><italic toggle="yes">Lahey Clin Found Bull</italic></source>. <year>1965</year>;<volume>14</volume>(<issue>1</issue>):<fpage>21</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">5828637</pub-id></mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Grubb</surname><given-names>TC</given-names></string-name>. <article-title>Narcolepsy and highway accidents</article-title>. <source><italic toggle="yes">JAMA</italic></source>. <year>1969</year>;<volume>209</volume>(<issue>11</issue>):<fpage>1720</fpage>.</mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Thorpy</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Krieger</surname><given-names>AC</given-names></string-name>. <article-title>Delayed diagnosis of narcolepsy: characterization and impact</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2014</year>;<volume>15</volume>(<issue>5</issue>):<fpage>502</fpage>–<lpage>507</lpage>.<pub-id pub-id-type="pmid">24780133</pub-id></mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Frauscher</surname><given-names>B</given-names></string-name>, <string-name><surname>Ehrmann</surname><given-names>L</given-names></string-name>, <string-name><surname>Mitterling</surname><given-names>T</given-names></string-name>, et al. <article-title>Delayed diagnosis, range of severity, and multiple sleep comorbidities: a clinical and polysomnographic analysis of 100 patients of the Innsbruck narcolepsy cohort</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2013</year>;<volume>9</volume>(<issue>8</issue>):<fpage>805</fpage>–<lpage>812</lpage>.<pub-id pub-id-type="pmid">23946711</pub-id></mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Luca</surname><given-names>G</given-names></string-name>, <string-name><surname>Haba-Rubio</surname><given-names>J</given-names></string-name>, <string-name><surname>Dauvilliers</surname><given-names>Y</given-names></string-name>, et al. <article-title>Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2013</year>;<volume>22</volume>(<issue>5</issue>):<fpage>482</fpage>–<lpage>495</lpage>.<pub-id pub-id-type="pmid">23496005</pub-id></mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Aldrich</surname><given-names>MS</given-names></string-name>. <article-title>Automobile accidents in patients with sleep disorders</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>1989</year>;<volume>12</volume>(<issue>6</issue>):<fpage>487</fpage>–<lpage>494</lpage>.<pub-id pub-id-type="pmid">2595172</pub-id></mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Hong</surname><given-names>S</given-names></string-name>, <string-name><surname>Son</surname><given-names>DK</given-names></string-name>, <string-name><surname>Lim</surname><given-names>WR</given-names></string-name>, et al. <article-title>The prevalence of atopic dermatitis, asthma, and allergic rhinitis and the comorbidity of allergic diseases in children</article-title>. <source><italic toggle="yes">Environ Health Toxicol</italic></source>. <year>2012</year>;<volume>27</volume>:<fpage>e2012006</fpage>.<pub-id pub-id-type="pmid">22359737</pub-id></mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Grize</surname><given-names>L</given-names></string-name>, <string-name><surname>Gassner</surname><given-names>M</given-names></string-name>, <string-name><surname>Wuthrich</surname><given-names>B</given-names></string-name>, et al. <article-title>Trends in prevalence of asthma, allergic rhinitis and atopic dermatitis in 5-7-year old Swiss children from 1992 to 2001</article-title>. <source><italic toggle="yes">Allergy</italic></source>. <year>2006</year>;<volume>61</volume>(<issue>5</issue>):<fpage>556</fpage>–<lpage>562</lpage>.<pub-id pub-id-type="pmid">16629784</pub-id></mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yan</surname><given-names>DC</given-names></string-name>, <string-name><surname>Ou</surname><given-names>LS</given-names></string-name>, <string-name><surname>Tsai</surname><given-names>TL</given-names></string-name>, <string-name><surname>Wu</surname><given-names>WF</given-names></string-name>, <string-name><surname>Huang</surname><given-names>JL</given-names></string-name>. <article-title>Prevalence and severity of symptoms of asthma, rhinitis, and eczema in 13- to 14-year-old children in Taipei, Taiwan</article-title>. <source><italic toggle="yes">Ann Allergy Asthma Immunol</italic></source>. <year>2005</year>;<volume>95</volume>(<issue>6</issue>):<fpage>579</fpage>–<lpage>585</lpage>.<pub-id pub-id-type="pmid">16400899</pub-id></mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cukic</surname><given-names>V</given-names></string-name>, <string-name><surname>Lovre</surname><given-names>V</given-names></string-name>, <string-name><surname>Dragisic</surname><given-names>D</given-names></string-name>. <article-title>Sleep disorders in patients with bronchial asthma</article-title>. <source><italic toggle="yes">Mater Sociomed</italic></source>. <year>2011</year>;<volume>23</volume>(<issue>4</issue>):<fpage>235</fpage>–<lpage>237</lpage>.<pub-id pub-id-type="pmid">23678304</pub-id></mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bernard-Valnet</surname><given-names>R</given-names></string-name>, <string-name><surname>Yshii</surname><given-names>L</given-names></string-name>, <string-name><surname>Queriault</surname><given-names>C</given-names></string-name>, et al. <article-title>CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice</article-title>. <source><italic toggle="yes">Proc Natl Acad Sci USA</italic></source>. <year>2016</year>;<volume>113</volume>(<issue>39</issue>):<fpage>10956</fpage>–<lpage>10961</lpage>.<pub-id pub-id-type="pmid">27621438</pub-id></mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Latorre</surname><given-names>D</given-names></string-name>, <string-name><surname>Kallweit</surname><given-names>U</given-names></string-name>, <string-name><surname>Armentani</surname><given-names>E</given-names></string-name>, et al. <article-title>T cells in patients with narcolepsy target self-antigens of hypocretin neurons</article-title>. <source><italic toggle="yes">Nature</italic></source>. <year>2018</year>;<volume>562</volume>(<issue>7725</issue>):<fpage>63</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="pmid">30232458</pub-id></mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Martinez-Orozco</surname><given-names>FJ</given-names></string-name>, <string-name><surname>Vicario</surname><given-names>JL</given-names></string-name>, <string-name><surname>Villalibre-Valderrey</surname><given-names>I</given-names></string-name>, <string-name><surname>De Andres</surname><given-names>C</given-names></string-name>, <string-name><surname>Fernandez-Arquero</surname><given-names>M</given-names></string-name>, <string-name><surname>Peraita-Adrados</surname><given-names>R</given-names></string-name>. <article-title>Narcolepsy with cataplexy and comorbid immunopathological diseases</article-title>. <source><italic toggle="yes">J Sleep Res</italic></source>. <year>2014</year>;<volume>23</volume>(<issue>4</issue>):<fpage>414</fpage>–<lpage>419</lpage>.<pub-id pub-id-type="pmid">24645699</pub-id></mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Aydinoz</surname><given-names>S</given-names></string-name>, <string-name><surname>Huang</surname><given-names>YS</given-names></string-name>, <string-name><surname>Gozal</surname><given-names>D</given-names></string-name>, <string-name><surname>Inocente</surname><given-names>CO</given-names></string-name>, <string-name><surname>Franco</surname><given-names>P</given-names></string-name>, <string-name><surname>Kheirandish-Gozal</surname><given-names>L</given-names></string-name>. <article-title>Allergies and disease severity in childhood narcolepsy: preliminary findings</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2015</year>;<volume>38</volume>(<issue>12</issue>):<fpage>1981</fpage>–<lpage>1984</lpage>.<pub-id pub-id-type="pmid">25902808</pub-id></mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Alomar</surname><given-names>M</given-names></string-name>, <string-name><surname>Almeneessier</surname><given-names>AS</given-names></string-name>, <string-name><surname>Olaish</surname><given-names>AH</given-names></string-name>, <string-name><surname>Alshiban</surname><given-names>A</given-names></string-name>, <string-name><surname>Alomar</surname><given-names>A</given-names></string-name>, <string-name><surname>BaHammam</surname><given-names>AS</given-names></string-name>. <article-title>Immune-mediated comorbidities in Saudi patients with narcolepsy</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2019</year>;<volume>11</volume>:<fpage>35</fpage>–<lpage>43</lpage>.<pub-id pub-id-type="pmid">31118849</pub-id></mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Huang</surname><given-names>HL</given-names></string-name>, <string-name><surname>Ho</surname><given-names>SY</given-names></string-name>, <string-name><surname>Li</surname><given-names>CH</given-names></string-name>, et al. <article-title>Bronchial asthma is associated with increased risk of chronic kidney disease</article-title>. <source><italic toggle="yes">BMC Pulm Med</italic></source>. <year>2014</year>;<volume>14</volume>:<fpage>80</fpage>.<pub-id pub-id-type="pmid">24885269</pub-id></mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tang</surname><given-names>YJ</given-names></string-name>, <string-name><surname>Ho</surname><given-names>SY</given-names></string-name>, <string-name><surname>Chu</surname><given-names>FY</given-names></string-name>, et al. <article-title>Is Zolpidem associated with increased risk of fractures in the elderly with sleep disorders? A nationwide case cross-over study in Taiwan</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2015</year>;<volume>10</volume>(<issue>12</issue>):<fpage>e0146030</fpage>.<pub-id pub-id-type="pmid">26716836</pub-id></mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chen</surname><given-names>TY</given-names></string-name>, <string-name><surname>Winkelman</surname><given-names>JW</given-names></string-name>, <string-name><surname>Mao</surname><given-names>WC</given-names></string-name>, <string-name><surname>Liu</surname><given-names>CL</given-names></string-name>, <string-name><surname>Hsu</surname><given-names>CY</given-names></string-name>, <string-name><surname>Wu</surname><given-names>CS</given-names></string-name>. <article-title>The use of benzodiazepine receptor agonists and the risk of hospitalization for pneumonia: a nationwide population-based nested case-control study</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2018</year>;<volume>153</volume>(<issue>1</issue>):<fpage>161</fpage>–<lpage>171</lpage>.<pub-id pub-id-type="pmid">28782528</pub-id></mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tzeng</surname><given-names>NS</given-names></string-name>, <string-name><surname>Chang</surname><given-names>HA</given-names></string-name>, <string-name><surname>Chung</surname><given-names>CH</given-names></string-name>, et al. <article-title>Increased risk of psychiatric disorders in allergic diseases: a nationwide, population-based, cohort study</article-title>. <source><italic toggle="yes">Front Psychiatry</italic></source>. <year>2018</year>;<volume>9</volume>:<fpage>133</fpage>.<pub-id pub-id-type="pmid">29740354</pub-id></mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Tseng</surname><given-names>WS</given-names></string-name>, <string-name><surname>Chien</surname><given-names>WC</given-names></string-name>, <string-name><surname>Chung</surname><given-names>CH</given-names></string-name>, <string-name><surname>Chou</surname><given-names>YC</given-names></string-name>, <string-name><surname>Tzeng</surname><given-names>NS</given-names></string-name>. <article-title>Risk of sleep disorders in patients with decompression sickness: a nationwide, population-based study in Taiwan</article-title>. <source><italic toggle="yes">Psychiatr Danub</italic></source>. <year>2019</year>;<volume>31</volume>(<issue>2</issue>):<fpage>172</fpage>–<lpage>181</lpage>.<pub-id pub-id-type="pmid">31291221</pub-id></mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chen</surname><given-names>TY</given-names></string-name>, <string-name><surname>Liu</surname><given-names>CT</given-names></string-name>, <string-name><surname>Chung</surname><given-names>CH</given-names></string-name>, <string-name><surname>Hung</surname><given-names>SL</given-names></string-name>, <string-name><surname>Chien</surname><given-names>WC</given-names></string-name>, <string-name><surname>Chen</surname><given-names>JH</given-names></string-name>. <article-title>Bariatric surgery may provide better protection than uvulopalatopharyngoplasty against major adverse cardiovascular events in obese patients with obstructive sleep apnea</article-title>. <source><italic toggle="yes">Surg Obes Relat Dis</italic></source>. <year>2021</year>;<volume>17</volume>(<issue>4</issue>):<fpage>780</fpage>–<lpage>791</lpage>.<pub-id pub-id-type="pmid">33423961</pub-id></mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Su</surname><given-names>VY</given-names></string-name>, <string-name><surname>Yang</surname><given-names>KY</given-names></string-name>, <string-name><surname>Yang</surname><given-names>YH</given-names></string-name>, et al. <article-title>Use of ICS/LABA combinations or LAMA is associated with a lower risk of acute exacerbation in patients with coexistent COPD and asthma</article-title>. <source><italic toggle="yes">J Allergy Clin Immunol Pract</italic></source>. <year>2018</year>;<volume>6</volume>(<issue>6</issue>):<fpage>1927</fpage>–<lpage>1935</lpage>.<pub-id pub-id-type="pmid">29432960</pub-id></mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Su</surname><given-names>VY</given-names></string-name>, <string-name><surname>Liu</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Wang</surname><given-names>HK</given-names></string-name>, et al. <article-title>Sleep apnea and risk of pneumonia: a nationwide population-based study</article-title>. <source><italic toggle="yes">Can Med Assoc J</italic></source>. <year>2014</year>;<volume>186</volume>(<issue>6</issue>):<fpage>415</fpage>–<lpage>421</lpage>.<pub-id pub-id-type="pmid">24591276</pub-id></mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Su</surname><given-names>VY</given-names></string-name>, <string-name><surname>Su</surname><given-names>WJ</given-names></string-name>, <string-name><surname>Yen</surname><given-names>YF</given-names></string-name>, et al. <article-title>Statin use is associated with a lower risk of TB</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2017</year>;<volume>152</volume>(<issue>3</issue>):<fpage>598</fpage>–<lpage>606</lpage>.<pub-id pub-id-type="pmid">28479115</pub-id></mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chang</surname><given-names>CY</given-names></string-name>, <string-name><surname>Chen</surname><given-names>WL</given-names></string-name>, <string-name><surname>Liou</surname><given-names>YF</given-names></string-name>, et al. <article-title>Increased risk of major depression in the three years following a femoral neck fracture–a national population-based follow-up study</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2014</year>;<volume>9</volume>(<issue>3</issue>):<fpage>e89867</fpage>.<pub-id pub-id-type="pmid">24626193</pub-id></mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chang</surname><given-names>YL</given-names></string-name>, <string-name><surname>Ko</surname><given-names>HK</given-names></string-name>, <string-name><surname>Lu</surname><given-names>MS</given-names></string-name>, et al. <article-title>Independent risk factors for death in patients admitted for asthma exacerbation in Taiwan</article-title>. <source><italic toggle="yes">NPJ Prim Care Respir Med</italic></source>. <year>2020</year>;<volume>30</volume>(<issue>1</issue>):<fpage>7</fpage>.<pub-id pub-id-type="pmid">32193384</pub-id></mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Parimon</surname><given-names>T</given-names></string-name>, <string-name><surname>Chien</surname><given-names>JW</given-names></string-name>, <string-name><surname>Bryson</surname><given-names>CL</given-names></string-name>, <string-name><surname>McDonell</surname><given-names>MB</given-names></string-name>, <string-name><surname>Udris</surname><given-names>EM</given-names></string-name>, <string-name><surname>Au</surname><given-names>DH</given-names></string-name>. <article-title>Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2007</year>;<volume>175</volume>(<issue>7</issue>):<fpage>712</fpage>–<lpage>719</lpage>.<pub-id pub-id-type="pmid">17185647</pub-id></mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Huang</surname><given-names>YC</given-names></string-name>, <string-name><surname>Chan</surname><given-names>WC</given-names></string-name>, <string-name><surname>Wang</surname><given-names>JD</given-names></string-name>, <string-name><surname>Fu</surname><given-names>LS</given-names></string-name>, <string-name><surname>Tsan</surname><given-names>YT</given-names></string-name>. <article-title>Association between dry eye disease and asthma: a nationwide population-based study</article-title>. <source><italic toggle="yes">PeerJ</italic></source>. <year>2018</year>;<volume>6</volume>:<fpage>e5941</fpage>.<pub-id pub-id-type="pmid">30568850</pub-id></mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kok</surname><given-names>VC</given-names></string-name>, <string-name><surname>Horng</surname><given-names>JT</given-names></string-name>, <string-name><surname>Huang</surname><given-names>HK</given-names></string-name>, <string-name><surname>Chao</surname><given-names>TM</given-names></string-name>, <string-name><surname>Hong</surname><given-names>YF</given-names></string-name>. <article-title>Regular inhaled corticosteroids in adult-onset asthma and the risk for future cancer: a population-based cohort study with proper person-time analysis</article-title>. <source><italic toggle="yes">Ther Clin Risk Manag</italic></source>. <year>2015</year>;<volume>11</volume>:<fpage>489</fpage>–<lpage>499</lpage>.<pub-id pub-id-type="pmid">25848295</pub-id></mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Wang</surname><given-names>WC</given-names></string-name>, <string-name><surname>Lu</surname><given-names>ML</given-names></string-name>, <string-name><surname>Chen</surname><given-names>VC</given-names></string-name>, et al. <article-title>Asthma, corticosteroid use and schizophrenia: a nationwide population-based study in Taiwan</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2017</year>;<volume>12</volume>(<issue>3</issue>):<fpage>e0173063</fpage>.<pub-id pub-id-type="pmid">28350822</pub-id></mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Castillo</surname><given-names>EF</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>H</given-names></string-name>, <string-name><surname>Yang</surname><given-names>XO</given-names></string-name>. <article-title>Orchestration of epithelial-derived cytokines and innate immune cells in allergic airway inflammation</article-title>. <source><italic toggle="yes">Cytokine Growth Factor Rev</italic></source>. <year>2018</year>;<volume>39</volume>:<fpage>19</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">29169815</pub-id></mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="book"><string-name><surname>Arora</surname><given-names>P</given-names></string-name>, <string-name><surname>Ansari</surname><given-names>SH</given-names></string-name>. <part-title>Role of various mediators in inflammation of asthmatic airways</part-title>. In: <string-name><surname>Pereira</surname><given-names>C</given-names></string-name>, editor. <source><italic toggle="yes">Asthma-Biological Evidences</italic></source>. <publisher-loc>London, United Kingdom</publisher-loc>: <publisher-name>IntechOpen</publisher-name>; <year>2019</year>:<fpage>1</fpage>–<lpage>14</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lecendreux</surname><given-names>M</given-names></string-name>, <string-name><surname>Churlaud</surname><given-names>G</given-names></string-name>, <string-name><surname>Pitoiset</surname><given-names>F</given-names></string-name>, et al. <article-title>Narcolepsy type 1 is associated with a systemic increase and activation of regulatory T cells and with a systemic activation of global T cells</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2017</year>;<volume>12</volume>(<issue>1</issue>):<fpage>e0169836</fpage>.<pub-id pub-id-type="pmid">28107375</pub-id></mixed-citation>
      </ref>
      <ref id="cit0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Vuorela</surname><given-names>A</given-names></string-name>, <string-name><surname>Freitag</surname><given-names>TL</given-names></string-name>, <string-name><surname>Leskinen</surname><given-names>K</given-names></string-name>, et al. <article-title>Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1</article-title>. <source><italic toggle="yes">Nat Commun</italic></source>. <year>2021</year>;<volume>12</volume>(<issue>1</issue>):<fpage>2283</fpage>.<pub-id pub-id-type="pmid">33863907</pub-id></mixed-citation>
      </ref>
      <ref id="cit0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cogswell</surname><given-names>AC</given-names></string-name>, <string-name><surname>Maski</surname><given-names>K</given-names></string-name>, <string-name><surname>Scammell</surname><given-names>TE</given-names></string-name>, <string-name><surname>Tucker</surname><given-names>D</given-names></string-name>, <string-name><surname>Orban</surname><given-names>ZS</given-names></string-name>, <string-name><surname>Koralnik</surname><given-names>IJ</given-names></string-name>. <article-title>Children with narcolepsy type 1 have increased T-cell responses to orexins</article-title>. <source><italic toggle="yes">Ann Clin Transl Neurol</italic></source>. <year>2019</year>;<volume>6</volume>(<issue>12</issue>):<fpage>2566</fpage>–<lpage>2572</lpage>.<pub-id pub-id-type="pmid">31730293</pub-id></mixed-citation>
      </ref>
      <ref id="cit0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Barateau</surname><given-names>L</given-names></string-name>, <string-name><surname>Lopez</surname><given-names>R</given-names></string-name>, <string-name><surname>Arnulf</surname><given-names>I</given-names></string-name>, et al. <article-title>Comorbidity between central disorders of hypersomnolence and immune-based disorders</article-title>. <source><italic toggle="yes">Neurology</italic></source>. <year>2017</year>;<volume>88</volume>(<issue>1</issue>):<fpage>93</fpage>–<lpage>100</lpage>.<pub-id pub-id-type="pmid">27864522</pub-id></mixed-citation>
      </ref>
      <ref id="cit0044">
        <label>44.</label>
        <mixed-citation publication-type="journal"><string-name><surname>De la Herran-arita</surname><given-names>AK</given-names></string-name>, <string-name><surname>Garcia-Garcia</surname><given-names>F</given-names></string-name>. <article-title>Narcolepsy as an immune-mediated disease</article-title>. <source><italic toggle="yes">Sleep Disord</italic></source>. <year>2014</year>;<volume>2014</volume>:<fpage>792687</fpage>.<pub-id pub-id-type="pmid">24551456</pub-id></mixed-citation>
      </ref>
      <ref id="cit0045">
        <label>45.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Guarnieri</surname><given-names>M</given-names></string-name>, <string-name><surname>Balmes</surname><given-names>JR</given-names></string-name>. <article-title>Outdoor air pollution and asthma</article-title>. <source><italic toggle="yes">Lancet</italic></source>. <year>2014</year>;<volume>383</volume>(<issue>9928</issue>):<fpage>1581</fpage>–<lpage>1592</lpage>.<pub-id pub-id-type="pmid">24792855</pub-id></mixed-citation>
      </ref>
      <ref id="cit0046">
        <label>46.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mortimer</surname><given-names>KM</given-names></string-name>, <string-name><surname>Neas</surname><given-names>LM</given-names></string-name>, <string-name><surname>Dockery</surname><given-names>DW</given-names></string-name>, <string-name><surname>Redline</surname><given-names>S</given-names></string-name>, <string-name><surname>Tager</surname><given-names>IB</given-names></string-name>. <article-title>The effect of air pollution on inner-city children with asthma</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>. <year>2002</year>;<volume>19</volume>(<issue>4</issue>):<fpage>699</fpage>–<lpage>705</lpage>.<pub-id pub-id-type="pmid">11999000</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
